M&A Deal Summary

Grupo Medinfar Acquires Lusomedicamenta Sociedade Técnica Farmacêutica S.A.

On October 1, 2020, Grupo Medinfar acquired life science company Lusomedicamenta Sociedade Técnica Farmacêutica S.A. from Recipharm for 26M EUR

Acquisition Highlights
  • This is Grupo Medinfar’s 1st transaction in the Life Science sector.
  • This is Grupo Medinfar’s largest (disclosed) transaction.
  • This is Grupo Medinfar’s 1st transaction in Sweden.

M&A Deal Summary
Date 2020-10-01
Target Lusomedicamenta Sociedade Técnica Farmacêutica S.A.
Sector Life Science
Buyer(s) Grupo Medinfar
Sellers(s) Recipharm
Deal Type Divestiture
Deal Value 26M EUR

Target

Lusomedicamenta Sociedade Técnica Farmacêutica S.A.

Jordbro, Sweden
Lusomedicamenta Sociedade Técnica Farmacêutica, S.A. focuses on cardiovascular disease, respiratory diseases and metabolic diseases.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Grupo Medinfar

Amadora, Portugal
Category Company
Founded 1970
Sector Life Science
DESCRIPTION

Grupo Medinfar is a fully integrated Pharmaceutical Company focused on Research, Development, Production, Distribution, Marketing & Sales. Grupo Medinfar produces and markets its own brands, such as Halibut, Trifene, or Aero-OM, as well as licensed products in partnership with major global pharmaceutical companies. Grupo Medinfar was founded in 1970 and is based in Amadora, Portugal.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
Country (Sweden) 1 of 1
Year (2020) 1 of 1
Size (of disclosed) 1 of 1

Seller(S) 1

SELLER

Recipharm

Stockholm, Sweden
Category Company
Founded 1995
Sector Life Science
Employees7,383
DESCRIPTION

Recipharm is a global Pharma CDMO providing a full-service offering to leading Pharmaceutical companies and Biotechs globally. Recipharm was founded in 1995 and is based in Stockholm, Sweden.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
Country (Sweden) 1 of 1
Year (2020) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-12-06 Consort Medical

Hemel Hempstead, United Kingdom

Consort Medical plc designs, develops, manufactures, and sells specialty medical drug delivery devices and services to the pharmaceutical industry in Europe, the United Kingdom, the United States, and internationally. Consort Medical was founded in 1946 and is based in Hemel Hempstead, the United Kingdom.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-02-18 Vibalogics

Boxborough, Massachusetts, United States

Vibalogics has operated as a specialized global Contract Development and Manufacturing Organization (CDMO) offering process and analytical development, manufacturing, testing, and fill-finish services to innovators developing transformational virotherapy products. Vibalogics GmbH was founded in 2002 and is based in Boxborough, Massachusetts.

Buy -
Mergr

Product

Company

Legal